QIAGEN Revenue 2010-2024 | QGEN

QIAGEN annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • QIAGEN revenue for the quarter ending September 30, 2024 was $0.502B, a 5.46% increase year-over-year.
  • QIAGEN revenue for the twelve months ending September 30, 2024 was $1.966B, a 0.62% increase year-over-year.
  • QIAGEN annual revenue for 2023 was $1.965B, a 8.23% decline from 2022.
  • QIAGEN annual revenue for 2022 was $2.142B, a 4.89% decline from 2021.
  • QIAGEN annual revenue for 2021 was $2.252B, a 20.39% increase from 2020.
QIAGEN Annual Revenue
(Millions of US $)
2023 $1,965
2022 $2,142
2021 $2,252
2020 $1,870
2019 $1,526
2018 $1,502
2017 $1,418
2016 $1,338
2015 $1,281
2014 $1,345
2013 $1,302
2012 $1,254
2011 $1,170
2010 $1,087
2009 $1,010
QIAGEN Quarterly Revenue
(Millions of US $)
2024-09-30 $502
2024-06-30 $496
2024-03-31 $459
2023-12-31 $509
2023-09-30 $476
2023-06-30 $495
2023-03-31 $485
2022-12-31 $498
2022-09-30 $500
2022-06-30 $516
2022-03-31 $628
2021-12-31 $582
2021-09-30 $535
2021-06-30 $567
2021-03-31 $567
2020-12-31 $571
2020-09-30 $484
2020-06-30 $443
2020-03-31 $372
2019-12-31 $413
2019-09-30 $383
2019-06-30 $382
2019-03-31 $349
2018-12-31 $403
2018-09-30 $378
2018-06-30 $377
2018-03-31 $344
2017-12-31 $397
2017-09-30 $364
2017-06-30 $349
2017-03-31 $308
2016-12-31 $367
2016-09-30 $339
2016-06-30 $334
2016-03-31 $298
2015-12-31 $349
2015-09-30 $315
2015-06-30 $319
2015-03-31 $298
2014-12-31 $360
2014-09-30 $336
2014-06-30 $331
2014-03-31 $317
2013-12-31 $361
2013-09-30 $322
2013-06-30 $315
2013-03-31 $304
2012-12-31 $347
2012-09-30 $304
2012-06-30 $307
2012-03-31 $296
2011-12-31 $334
2011-09-30 $289
2011-06-30 $282
2011-03-31 $264
2010-12-31 $286
2010-09-30 $274
2010-06-30 $263
2010-03-31 $264
2009-12-31 $289
2009-09-30 $260
2009-06-30 $240
2009-03-31 $221
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.865B $1.965B
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $160.636B 15.55
Vertex Pharmaceuticals (VRTX) United States $126.189B 0.00
Bristol Myers Squibb (BMY) United States $119.703B 50.44
Gilead Sciences (GILD) United States $117.465B 21.30
Regeneron Pharmaceuticals (REGN) United States $90.219B 20.53
CSL (CSLLY) Australia $89.966B 0.00
GSK (GSK) United Kingdom $73.617B 8.52
Argenex SE (ARGX) Netherlands $35.516B 0.00
Alnylam Pharmaceuticals (ALNY) United States $34.689B 0.00
BioNTech SE (BNTX) Germany $25.489B 0.00
Biogen (BIIB) United States $24.522B 10.53
Illumina (ILMN) United States $23.413B 85.33
BeiGene (BGNE) Cayman Islands $18.860B 0.00
Moderna (MRNA) United States $16.728B 0.00
Incyte (INCY) United States $15.524B 0.00
Genmab (GMAB) Denmark $14.870B 21.82
BioMarin Pharmaceutical (BMRN) United States $12.603B 29.26
Insmed (INSM) United States $12.548B 0.00
Vaxcyte (PCVX) United States $12.386B 0.00
Bio-Techne Corp (TECH) United States $11.823B 45.65
Sarepta Therapeutics (SRPT) United States $10.920B 98.55
Exelixis (EXEL) United States $10.238B 23.28
Revolution Medicines (RVMD) United States $9.980B 0.00
Intra-Cellular Therapies (ITCI) United States $9.381B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
Exact Sciences (EXAS) United States $9.283B 0.00
Roivant Sciences (ROIV) United Kingdom $8.608B 0.00
Repligen (RGEN) United States $8.322B 108.46
Ascendis Pharma (ASND) Denmark $7.742B 0.00
Halozyme Therapeutics (HALO) United States $7.584B 17.13
Legend Biotech (LEGN) United States $7.325B 0.00
Viking Therapeutics (VKTX) United States $6.753B 0.00
Cytokinetics (CYTK) United States $6.631B 0.00
Blueprint Medicines (BPMC) United States $6.138B 0.00
Nuvalent (NUVL) United States $5.896B 0.00
Avidity Biosciences (RNA) United States $5.575B 0.00
Arcellx (ACLX) United States $5.433B 0.00
Krystal Biotech (KRYS) United States $5.385B 89.15
ADMA Biologics Inc (ADMA) United States $5.077B 54.45
Biohaven (BHVN) United States $4.761B 0.00
Alkermes (ALKS) Ireland $4.729B 15.89
Axsome Therapeutics (AXSM) United States $4.725B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.418B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.330B 0.00
Denali Therapeutics (DNLI) United States $4.302B 0.00
Immunovant (IMVT) United States $4.296B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.937B 0.00
Guardant Health (GH) United States $3.673B 0.00
Apellis Pharmaceuticals (APLS) United States $3.640B 0.00
Merus (MRUS) Netherlands $3.535B 0.00
ImmunityBio (IBRX) United States $3.448B 0.00
Edgewise Therapeutics (EWTX) United States $3.333B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.315B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.287B 0.00
Kymera Therapeutics (KYMR) United States $3.238B 0.00
Amicus Therapeutics (FOLD) United States $3.134B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.118B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.047B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.983B 22.99
Iovance Biotherapeutics (IOVA) United States $2.953B 0.00
Zai Lab (ZLAB) China $2.885B 0.00
Janux Therapeutics (JANX) United States $2.773B 0.00
Vericel (VCEL) United States $2.759B 931.50
IDEAYA Biosciences (IDYA) United States $2.678B 0.00
Vera Therapeutics (VERA) United States $2.661B 0.00
Twist Bioscience (TWST) United States $2.652B 0.00
Keros Therapeutics (KROS) United States $2.628B 0.00
Apogee Therapeutics (APGE) United States $2.581B 0.00
Protagonist Therapeutics (PTGX) United States $2.573B 16.23
Belite Bio (BLTE) United States $2.484B 0.00
CG Oncology (CGON) United States $2.481B 0.00
SpringWorks Therapeutics (SWTX) United States $2.458B 0.00
Geron (GERN) United States $2.400B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.323B 0.00
Beam Therapeutics (BEAM) United States $2.314B 0.00
Ligand Pharmaceuticals (LGND) United States $2.281B 56.95
Bavarian Nordic (BVNRY) Denmark $2.277B 12.19
Akero Therapeutics (AKRO) United States $2.260B 0.00
Scholar Rock Holding (SRRK) United States $2.134B 0.00
Structure Therapeutics (GPCR) United States $2.115B 0.00
NeoGenomics (NEO) United States $2.096B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.017B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.001B 16.63
WAVE Life Sciences (WVE) Singapore $1.982B 0.00
Fortrea Holdings (FTRE) United States $1.969B 62.71
MannKind (MNKD) United States $1.953B 50.57
NovoCure (NVCR) Jersey $1.928B 0.00
Nurix Therapeutics (NRIX) United States $1.915B 0.00
Disc Medicine (IRON) United States $1.880B 0.00
Spyre Therapeutics (SYRE) United States $1.842B 0.00
Neumora Therapeutics (NMRA) United States $1.810B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.810B 0.00
Arvinas (ARVN) United States $1.808B 0.00
Galapagos (GLPG) Belgium $1.800B 0.00
Celldex Therapeutics (CLDX) United States $1.792B 0.00
Dynavax Technologies (DVAX) United States $1.775B 103.85
Certara (CERT) United States $1.706B 48.18
Intellia Therapeutics (NTLA) United States $1.696B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.688B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.660B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.577B 0.00
Praxis Precision Medicines (PRAX) United States $1.546B 0.00
Arcus Biosciences (RCUS) United States $1.535B 0.00
Gyre Therapeutics (GYRE) United States $1.496B 0.00
Myriad Genetics (MYGN) United States $1.472B 0.00
Travere Therapeutics (TVTX) United States $1.463B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.461B 0.00
Kura Oncology (KURA) United States $1.444B 0.00
Viridian Therapeutics (VRDN) United States $1.433B 0.00
Upstream Bio (UPB) United States $1.414B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.384B 0.00
Novavax (NVAX) United States $1.354B 0.00
ANI Pharmaceuticals (ANIP) United States $1.284B 17.48
Vir Biotechnology (VIR) United States $1.274B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.200B 0.00
Zymeworks (ZYME) United States $1.198B 0.00
Bicara Therapeutics (BCAX) United States $1.157B 0.00
Applied Therapeutics (APLT) United States $1.152B 0.00
Cogent Biosciences (COGT) United States $1.136B 0.00
Mesoblast (MESO) Australia $1.136B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.114B 0.00
ArriVent BioPharma (AVBP) United States $1.108B 0.00
MiMedx (MDXG) United States $1.096B 28.69
LENZ Therapeutics (LENZ) United States $1.024B 0.00
Immatics (IMTX) Germany $1.012B 0.00
Septerna (SEPN) $0.990B 0.00
CARGO Therapeutics (CRGX) United States $0.970B 0.00
89BIO (ETNB) United States $0.960B 0.00
Prothena (PRTA) Ireland $0.934B 0.00
Cullinan Therapeutics (CGEM) United States $0.933B 0.00
Castle Biosciences (CSTL) United States $0.918B 163.90
Cytek Biosciences (CTKB) United States $0.907B 0.00
Rapport Therapeutics (RAPP) United States $0.887B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.886B 0.00
Adaptive Biotechnologies (ADPT) United States $0.875B 0.00
AbCellera Biologics (ABCL) Canada $0.874B 0.00
Erasca (ERAS) United States $0.845B 0.00
Pliant Therapeutics (PLRX) United States $0.841B 0.00
Replimune (REPL) United States $0.833B 0.00
Zenas BioPharma (ZBIO) United States $0.820B 0.00
Dianthus Therapeutics (DNTH) United States $0.819B 0.00
Liquidia Technologies (LQDA) United States $0.816B 0.00
Tyra Biosciences (TYRA) United States $0.807B 0.00
Avid Bioservices (CDMO) United States $0.780B 0.00
Pacira BioSciences (PCRX) United States $0.776B 7.30
Anavex Life Sciences (AVXL) United States $0.765B 0.00
MBX Biosciences (MBX) United States $0.759B 0.00
Immunome (IMNM) United States $0.750B 0.00
Entrada Therapeutics (TRDA) United States $0.741B 12.45
Nuvation Bio (NUVB) United States $0.730B 0.00
Oric Pharmaceuticals (ORIC) United States $0.724B 0.00
Stoke Therapeutics (STOK) United States $0.721B 0.00
BioAge Labs (BIOA) United States $0.717B 0.00
CorMedix Inc (CRMD) United States $0.708B 0.00
Tectonic Therapeutic (TECX) United States $0.704B 0.00
Annexon (ANNX) United States $0.698B 0.00
Arbutus Biopharma (ABUS) United States $0.690B 0.00
Third Harmonic Bio (THRD) United States $0.678B 0.00
IGM Biosciences (IGMS) United States $0.673B 0.00
Mineralys Therapeutics (MLYS) United States $0.665B 0.00
Olema Pharmaceuticals (OLMA) United States $0.661B 0.00
AnaptysBio (ANAB) United States $0.654B 0.00
Abivax SA (ABVX) France $0.654B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.651B 0.00
CureVac (CVAC) Germany $0.645B 5.24
Sinovac Biotech (SVA) China $0.645B 0.00
Humacyte (HUMA) United States $0.640B 0.00
Sana Biotechnology (SANA) United States $0.634B 0.00
Astria Therapeutics (ATXS) United States $0.630B 0.00
Oculis Holding AG (OCS) Switzerland $0.607B 0.00
Allogene Therapeutics (ALLO) United States $0.595B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.595B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.591B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.590B 0.00
Emergent Biosolutions (EBS) United States $0.590B 0.00
ACELYRIN, INC (SLRN) United States $0.587B 0.00
Sangamo Therapeutics (SGMO) United States $0.564B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.561B 0.00
ChromaDex (CDXC) United States $0.554B 725.00
Celcuity (CELC) United States $0.553B 0.00
PureTech Health (PRTC) United States $0.547B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.544B 0.00
Alector (ALEC) United States $0.544B 0.00
Pharming Group (PHAR) Netherlands $0.543B 0.00
Alumis (ALMS) United States $0.536B 0.00
Q32 Bio (QTTB) United States $0.532B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.530B 0.00
Aura Biosciences (AURA) United States $0.528B 0.00
Neurogene (NGNE) United States $0.520B 0.00
REGENXBIO (RGNX) United States $0.520B 0.00
Prime Medicine (PRME) United States $0.519B 0.00
Contineum Therapeutics (CTNM) United States $0.505B 0.00
Terns Pharmaceuticals (TERN) United States $0.504B 0.00
Foghorn Therapeutics (FHTX) United States $0.493B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.491B 0.00
GH Research (GHRS) Ireland $0.476B 0.00
GRAIL (GRAL) United States $0.469B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.466B 0.00
Revance Therapeutics (RVNC) United States $0.433B 0.00
MeiraGTx Holdings (MGTX) United States $0.432B 0.00
Cartesian Therapeutics (RNAC) United States $0.430B 0.00
BioStem Technologies (BSEM) $0.415B 36.74
Absci (ABSI) United States $0.413B 0.00
Northwest Biotherapeutics (NWBO) United States $0.399B 0.00
Design Therapeutics (DSGN) United States $0.391B 0.00
C4 Therapeutics (CCCC) United States $0.389B 0.00
EnGene Holdings (ENGN) Canada $0.377B 0.00
MaxCyte (MXCT) United States $0.373B 0.00
Voyager Therapeutics (VYGR) United States $0.372B 9.62
XOMA Royalty (XOMA) United States $0.368B 0.00
Jasper Therapeutics (JSPR) United States $0.361B 0.00
Kamada (KMDA) Israel $0.360B 23.22
Tango Therapeutics (TNGX) United States $0.360B 0.00
Poseida Therapeutics (PSTX) United States $0.360B 0.00
Alpha Teknova (TKNO) United States $0.340B 0.00
Rezolute (RZLT) United States $0.337B 0.00
ITeos Therapeutics (ITOS) United States $0.336B 0.00
Sutro Biopharma (STRO) United States $0.334B 0.00
UniQure (QURE) Netherlands $0.328B 0.00
Codexis (CDXS) United States $0.327B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.325B 0.00
Semper Paratus Acquisition (TVGN) United States $0.323B 0.00
Artiva Biotherapeutics (ARTV) United States $0.317B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.315B 0.00
Nautilus Biotechnology (NAUT) United States $0.313B 0.00
Zura Bio (ZURA) United States $0.304B 0.00
AC Immune (ACIU) Switzerland $0.303B 0.00
Ocugen (OCGN) United States $0.294B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.293B 0.00
ATyr Pharma (ATYR) United States $0.293B 0.00
Biomea Fusion (BMEA) United States $0.290B 0.00
Urogen Pharma (URGN) United States $0.290B 0.00
Prima BioMed (IMMP) Australia $0.288B 0.00
TScan Therapeutics (TCRX) United States $0.287B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.283B 0.00
Atea Pharmaceuticals (AVIR) United States $0.281B 0.00
Fate Therapeutics (FATE) United States $0.271B 0.00
Mersana Therapeutics (MRSN) United States $0.270B 0.00
Kodiak Sciences (KOD) United States $0.267B 0.00
Abeona Therapeutics (ABEO) United States $0.264B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.264B 0.00
GENFIT S.A (GNFT) France $0.260B 0.00
Lifecore Biomedical (LFCR) United States $0.259B 0.00
Climb Bio (CLYM) United States $0.255B 0.00
Editas Medicine (EDIT) United States $0.253B 0.00
Anika Therapeutics (ANIK) United States $0.247B 0.00
Compass Therapeutics (CMPX) United States $0.246B 0.00
Inozyme Pharma (INZY) United States $0.242B 0.00
Opthea (OPT) Australia $0.241B 0.00
Precigen (PGEN) United States $0.240B 0.00
Inhibrx Biosciences (INBX) United States $0.240B 0.00
Eton Pharmaceuticals (ETON) United States $0.237B 0.00
Trevi Therapeutics (TRVI) United States $0.231B 0.00
CAMP4 Therapeutics (CAMP) United States $0.229B 0.00
Fulcrum Therapeutics (FULC) United States $0.227B 0.00
Amarin (AMRN) Ireland $0.227B 0.00
Kyverna Therapeutics (KYTX) United States $0.225B 0.00
2seventy Bio (TSVT) United States $0.220B 0.00
Solid Biosciences (SLDB) United States $0.220B 0.00
Instil Bio (TIL) United States $0.217B 0.00
XBiotech (XBIT) United States $0.216B 0.00
Nkarta (NKTX) United States $0.215B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.214B 0.00
Caribou Biosciences (CRBU) United States $0.212B 0.00
Nuvectis Pharma (NVCT) United States $0.212B 0.00
Cabaletta Bio (CABA) United States $0.210B 0.00
Molecular Partners AG (MOLN) Switzerland $0.209B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.203B 0.00
ScPharmaceuticals (SCPH) United States $0.197B 0.00
Verastem (VSTM) United States $0.196B 0.00
Gossamer Bio (GOSS) United States $0.192B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.191B 0.00
DiaMedica Therapeutics (DMAC) United States $0.184B 0.00
Black Diamond Therapeutics (BDTX) United States $0.183B 0.00
Sagimet Biosciences (SGMT) United States $0.182B 0.00
Greenwich LifeSciences (GLSI) United States $0.178B 0.00
Actuate Therapeutics (ACTU) United States $0.176B 0.00
Bright Minds Biosciences (DRUG) United States $0.176B 0.00
Tenaya Therapeutics (TNYA) United States $0.175B 0.00
Adverum Biotechnologies (ADVM) United States $0.164B 0.00
Skye Bioscience (SKYE) United States $0.164B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.161B 0.00
Cardiff Oncology (CRDF) United States $0.161B 0.00
Akoya Biosciences (AKYA) United States $0.158B 0.00
Puma Biotechnology (PBYI) United States $0.158B 6.69
Checkpoint Therapeutics (CKPT) United States $0.155B 0.00
Innate Pharma S.A (IPHA) France $0.154B 0.00
Repare Therapeutics (RPTX) Canada $0.149B 0.00
Ventyx Biosciences (VTYX) United States $0.148B 0.00
Oncobiologics (OTLK) United States $0.148B 0.00
PepGen (PEPG) United States $0.148B 0.00
Scilex Holding (SCLX) United States $0.148B 0.00
Vigil Neuroscience (VIGL) United States $0.147B 0.00
Candel Therapeutics (CADL) United States $0.143B 0.00
Compugen (CGEN) Israel $0.143B 80.00
Seer (SEER) United States $0.139B 0.00
Inventiva S.A (IVA) France $0.139B 0.00
Rani Therapeutics Holdings (RANI) United States $0.137B 0.00
Generation Bio (GBIO) United States $0.137B 0.00
Inovio Pharmaceuticals (INO) United States $0.134B 0.00
Elutia (ELUT) United States $0.129B 0.00
INmune Bio (INMB) United States $0.126B 0.00
Allakos (ALLK) United States $0.122B 0.00
Alto Neuroscience (ANRO) United States $0.121B 0.00
Coya Therapeutics (COYA) United States $0.121B 0.00
Invivyd (IVVD) United States $0.119B 0.00
Adherex Technologies (FENC) United States $0.116B 0.00
23andMe Holding (ME) United States $0.115B 0.00
Adlai Nortye (ANL) Cayman Islands $0.115B 0.00
Benitec Biopharma (BNTC) United States $0.115B 0.00
Seres Therapeutics (MCRB) United States $0.113B 0.00
MediciNova (MNOV) United States $0.112B 0.00
FibroBiologics (FBLG) United States $0.111B 0.00
Cellectis S.A (CLLS) France $0.110B 0.00
PDS Biotechnology (PDSB) United States $0.109B 0.00
Adagene (ADAG) China $0.108B 0.00
BioAtla (BCAB) United States $0.106B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.105B 0.00
Annovis Bio (ANVS) United States $0.104B 0.00
Immunic (IMUX) United States $0.104B 0.00
Genelux (GNLX) United States $0.102B 0.00
Renovaro (RENB) United States $0.102B 0.00
X4 Pharmaceuticals (XFOR) United States $0.100B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.100B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.099B 0.00
Adicet Bio (ACET) United States $0.099B 0.00
HilleVax (HLVX) United States $0.099B 0.00
Werewolf Therapeutics (HOWL) United States $0.096B 0.00
Coherus BioSciences (CHRS) United States $0.095B 0.00
Cidara Therapeutics (CDTX) United States $0.095B 0.00
Monopar Therapeutics (MNPR) United States $0.091B 0.00
Chimerix (CMRX) United States $0.089B 0.00
InflaRx (IFRX) Germany $0.089B 0.00
Ovid Therapeutics (OVID) United States $0.088B 0.00
Genenta Science S.p.A (GNTA) Italy $0.088B 0.00
Galena Biopharma (SLS) United States $0.087B 0.00
I-Mab (IMAB) China $0.086B 0.00
Oncolytics Biotech (ONCY) Canada $0.086B 0.00
Ikena Oncology (IKNA) United States $0.085B 0.00
Celularity (CELU) United States $0.084B 0.00
Leap Therapeutics (LPTX) United States $0.083B 0.00
Aileron Therapeutics (ALRN) United States $0.083B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
Cue Biopharma (CUE) United States $0.083B 0.00
Boundless Bio (BOLD) United States $0.083B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.082B 0.00
VistaGen Therapeutics (VTGN) United States $0.082B 0.00
CytomX Therapeutics (CTMX) United States $0.081B 6.12
Eupraxia Pharmaceuticals (EPRX) Canada $0.079B 0.00
TELA Bio (TELA) United States $0.077B 0.00
Aerovate Therapeutics (AVTE) United States $0.077B 0.00
Bluebird Bio (BLUE) United States $0.076B 0.00
ZIVO Bioscience (ZIVO) United States $0.074B 0.00
Syros Pharmaceuticals (SYRS) United States $0.073B 0.00
CervoMed (CRVO) United States $0.073B 0.00
Quince Therapeutics (QNCX) United States $0.073B 0.00
BeyondSpring (BYSI) United States $0.073B 0.00
Spero Therapeutics (SPRO) United States $0.071B 3.22
ALX Oncology Holdings (ALXO) United States $0.071B 0.00
Vor Biopharma (VOR) $0.068B 0.00
Agenus (AGEN) United States $0.067B 0.00
Precision BioSciences (DTIL) United States $0.064B 0.00
Omega Therapeutics (OMGA) United States $0.063B 0.00
DBV Technologies S.A (DBVT) France $0.061B 0.00
IO Biotech (IOBT) Denmark $0.061B 0.00
Rapt Therapeutics (RAPT) United States $0.061B 0.00
Enzo Biochem (ENZ) United States $0.061B 0.00
Shattuck Labs (STTK) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Theratechnologies (THTX) Canada $0.058B 0.00
OnKure Therapeutics (OKUR) United States $0.058B 0.00
Connect Biopharma Holdings (CNTB) United States $0.057B 0.00
Atara Biotherapeutics (ATRA) United States $0.057B 0.00
Affimed (AFMD) Germany $0.057B 0.00
Aligos Therapeutics (ALGS) United States $0.057B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.056B 0.00
Kronos Bio (KRON) United States $0.055B 0.00
Kezar Life Sciences (KZR) United States $0.055B 0.00
Immuneering (IMRX) United States $0.054B 0.00
Elicio Therapeutics (ELTX) United States $0.054B 0.00
Aadi Bioscience (AADI) United States $0.053B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.051B 0.00
Xilio Therapeutics (XLO) United States $0.047B 0.00
Immix Biopharma (IMMX) United States $0.047B 0.00
BGM Group (BGM) China $0.047B 0.00
Intensity Therapeutics (INTS) United States $0.047B 0.00
Imunon (IMNN) United States $0.047B 0.00
Rallybio (RLYB) United States $0.046B 0.00
HOOKIPA Pharma (HOOK) United States $0.043B 0.00
NextCure (NXTC) United States $0.043B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.043B 0.00
VTv Therapeutics (VTVT) United States $0.042B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.042B 0.00
Passage Bio (PASG) United States $0.041B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.041B 0.00
Elevation Oncology (ELEV) United States $0.041B 0.00
Fortress Biotech (FBIO) United States $0.039B 0.00
Lantern Pharma (LTRN) United States $0.039B 0.00
Lumos Pharma (LUMO) United States $0.038B 0.00
Dare Bioscience (DARE) United States $0.038B 0.00
CalciMedica (CALC) United States $0.038B 0.00
OKYO Pharma (OKYO) $0.037B 0.00
Lexaria Bioscience (LEXX) Canada $0.036B 0.00
Clene (CLNN) United States $0.036B 0.00
Dyadic (DYAI) United States $0.034B 0.00
Longeveron (LGVN) United States $0.033B 0.00
KALA BIO (KALA) United States $0.033B 0.00
Eyenovia (EYEN) United States $0.032B 0.00
Grace Therapeutics (GRCE) Canada $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
SAB Biotherapeutics (SABS) United States $0.032B 0.00
Athira Pharma (ATHA) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Pluri (PLUR) Israel $0.030B 0.00
Equillium (EQ) United States $0.030B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.030B 0.00
Opus Genetics (IRD) United States $0.030B 0.00
LakeShore Biopharma (LSB) China $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
Estrella Immunopharma (ESLA) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
GeoVax Labs (GOVX) United States $0.027B 0.00
BioXcel Therapeutics (BTAI) United States $0.027B 0.00
Chemomab Therapeutics (CMMB) Israel $0.027B 0.00
RenovoRx (RNXT) United States $0.026B 0.00
Ocean Biomedical (OCEA) United States $0.026B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.025B 0.00
Curis (CRIS) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Cognition Therapeutics (CGTX) United States $0.024B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.024B 0.00
Beyond Air (XAIR) United States $0.023B 0.00
BRIACELL THERAP (BCTX) Canada $0.023B 0.00
Femasys (FEMY) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
UNITY Biotechnology (UBX) United States $0.022B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
Spruce Biosciences (SPRB) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
Gelteq (GELS) $0.021B 0.00
Cadrenal Therapeutics (CVKD) United States $0.019B 0.00
Cara Therapeutics (CARA) United States $0.019B 0.00
Aprea Therapeutics (APRE) United States $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
BioAffinity Technologies (BIAF) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Tenax Therapeutics (TENX) United States $0.017B 0.00
IN8bio (INAB) United States $0.016B 0.00
Sensei Biotherapeutics (SNSE) United States $0.014B 0.00
Cingulate (CING) United States $0.013B 0.00
Turnstone Biologics (TSBX) United States $0.013B 0.00
Evaxion Biotech (EVAX) Denmark $0.013B 0.00
Apollomics (APLM) United States $0.013B 0.00
HCW Biologics (HCWB) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Evogene (EVGN) Israel $0.011B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Vincerx Pharma (VINC) United States $0.010B 0.00
Biora Therapeutics (BIOR) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Galecto (GLTO) Denmark $0.009B 0.00
NKGen Biotech (NKGN) United States $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Forte Biosciences (FBRX) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
TuHURA Biosciences (HURA) United States $0.008B 0.00
Edesa Biotech (EDSA) Canada $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.006B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
Carmell (CTCX) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Exicure (XCUR) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Dogwood Therapeutics (DWTX) United States $0.005B 0.00
Polyrizon (PLRZ) $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Onconetix (ONCO) United States $0.001B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Elevai Labs (ELAB) United States $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00